New nanotechnology approaches for treatment and palliative care of cancer

Ayushmita Mishra; Kajal  Shukla; Gagan  Sagar

doi:10.55006/biolsciences.2022.2301

Authors

Ayushmita Mishra Government Pharmacy College, BRD Medical College, Campus, Gorakhpur, U.P, India
Kajal Shukla Government Pharmacy College, BRD Medical College, Campus, Gorakhpur, U.P, India
Gagan Sagar Government Pharmacy College, BRD Medical College, Campus, Gorakhpur, U.P, India

DOI:

https://doi.org/10.55006/biolsciences.2022.2301

Keywords:

Nanotechnology, Drug delivery, Diagnosis, Nanoparticles, Palliative care

Abstract

Cancer is one of the major reasons which leads to worldwide mortality and this proportion is increasing day by day, hence advanced better treatments are required to develop. Nanotechnology, or the science of the very small, has immense potential in healthcare, from more effective drug delivery to more rapid and sensitive illness diagnosis. Traditional cancer treatments run the risk of harming healthy tissues while attempting to destroy malignant cells. By controlling medications to selectively target tumor cells, nanotechnology ameliorate chemotherapy and decreases its side effects. The US Food and Drug Administration has already approved the first generation of cancer treatments delivered by nanoparticles (FDA). The application of nanotechnology to cancer detection and medicine delivery has received a lot of attention. It can detect the chemical which relates to cancer quickly and sensitively, allowing scientists to detect molecular changes in a small fraction of cells. Nanotechnology has the potential or we can say it has an innovative approach to develop effective medicinal treatments. Cancer detection, treatment, drug administration, imaging and diagnostic techniques, and immunotherapy will all be discussed in this review paper.

This article is a part of Special Issue "Advances in the field of Nanomedicine"

Downloads

Download data is not yet available.

References

Gmeiner WH, Ghosh S. Nanotechnology for cancer treatment. Nanotechnology reviews. 2014 Apr 1;3(2):111-22.

Robertson FM, Ferrari M. Introduction and rationale for nanotechnology in cancer therapy. InNanotechnology for cancer therapy 2006 Dec 19 (pp. 3-10). CRC Press.

Kemp JA, Kwon YJ. Cancer nanotechnology: current status and perspectives. Nano convergence. 2021 Dec;8(1):1-38.

Martinelli C, Pucci C, Ciofani G. Nanostructured carriers as innovative tools for cancer diagnosis and therapy. APL bioengineering. 2019 Mar 26;3(1):011502.

Sutradhar KB, Amin ML. Nanotechnology in cancer drug delivery and selective targeting. ISRN Nanotechnology 2014: 1–12.

Peng CW, Li Y. Application of quantum dots-based biotechnology in cancer diagnosis: current status and future perspectives. Journal of Nanomaterials. 2010 Jan 1;2010.

Sun M, Wang T, Li L, Li X, Zhai Y, Zhang J, Li W. The application of inorganic nanoparticles in molecular targeted cancer therapy: EGFR targeting. Frontiers in Pharmacology. 2021;12.

Wolfram J, Zhu M, Yang Y, Shen J, Gentile E, Paolino D, Fresta M, Nie G, Chen C, Shen H, Ferrari M. Safety of nanoparticles in medicine. Current drug targets. 2015 Dec 1;16(14):1671-81.

Attia MF, Anton N, Wallyn J, Omran Z, Vandamme TF. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. Journal of Pharmacy and Pharmacology. 2019 Aug;71(8):1185-98.

Bazak R, Houri M, El Achy S, Hussein W, Refaat T. Passive targeting of nanoparticles to cancer: A comprehensive review of the literature. Molecular and clinical oncology. 2014 Nov 1;2(6):904-8.

Heidel JD, Davis ME. Clinical developments in nanotechnology for cancer therapy. Pharmaceutical research. 2011 Feb;28(2):187-99.

Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, Wu S, Deng Y, Zhang J, Shao A. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Frontiers in Molecular Biosciences. 2020 Aug 20;7:193.

Toy R, Bauer L, Hoimes C, Ghaghada KB, Karathanasis E. Targeted nanotechnology for cancer imaging. Advanced drug delivery reviews. 2014 Sep 30;76:79-97.

Joshi A. -Imaging with Nanoparticles. InCancer Nanotechnology 2016 Apr 19 (pp. 82-95). CRC Press.

Mrsny RJ. Active targeting strategies in cancer with a focus on potential nanotechnology applications. InNanotechnology for cancer therapy 2006 Dec 19 (pp. 19-42). CRC Press.

Liu A, Liang N, Liu Y, Mu Y, Su G, Yan B. Safety Concerns for Nanomaterials in Nanomedicinal Applications. Cancer Nanotechnology: Principles and Applications in Radiation Oncology. 2013 Jan 8:49.

Wolfram J, Zhu M, Yang Y, Shen J, Gentile E, Paolino D, Fresta M, Nie G, Chen C, Shen H, Ferrari M. Safety of nanoparticles in medicine. Current drug targets. 2015 Dec 1;16(14):1671-81.

Grodzinski P, Silver M, Molnar LK. Nanotechnology for cancer diagnostics: promises and challenges. Expert review of molecular diagnostics. 2006 May 1;6(3):307-18.